CVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
CVS Pharmacy is recalling Infant's Grape Flavored Acetaminophen Oral Suspension nationwide because the product was manufactured with a contaminated excipient that was recalled from its supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall, and the source text describes a CGMP (Current Good Manufacturing Practice) deviation involving a contaminated excipient. The source text does not report any illnesses or injuries, making this a manufacturing or precautionary recall. Per the rubric, this qualifies as Moderate.
Plain-English summary
CVS Pharmacy, Inc. is recalling Infant's Grape Flavored Acetaminophen Oral Suspension, 160mg/5ml, 2 FL OZ (59 mL) bottles distributed nationwide. The product was manufactured by Perrigo Company PLC. According to the FDA, the recall was initiated because the product was manufactured with a contaminated excipient that had been recalled from the excipient supplier.
Affected batches are 1CK1276, 1FK1184, 1GK0821, and 1EK1046, with expiration date 02/28/2023. The NDC number is 59779-946-16. A total of 37,152 bottles were distributed.
Consumers who have purchased this product should stop using it and consult their healthcare provider or pharmacist for guidance. For more information, consumers can contact CVS Pharmacy, Inc. at One CVS Drive, Woonsocket, RI 02895.
The recalled product
- Product
- Infant's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) per bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC: 59779-946-16
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Pediatric Suspension
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch: 1CK1276
- 1FK1184
- 1GK0821 and 1EK1046
- Exp 02/28/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27